Related Experiment Videos
[Cardiac side effects and ECG changes with lamotrigine?--A clinical study]
B J Steinhoff1, S R Stodieck, F P Tiecks
1Abteilung Klinische Neurophysiologie, Georg-August-Universität, Göttingen.
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)
|January 1, 1994
Summary
This study found lamotrigine (LTG) did not cause significant cardiovascular side effects in epilepsy patients. ECGs showed no elevated risk of clinically relevant cardiac issues with LTG use.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Lamotrigine (LTG) is an antiepileptic drug (AED) used for epilepsy.
- Concerns exist regarding potential cardiovascular side effects of LTG.
Purpose of the Study:
- To prospectively investigate cardiovascular side effects of lamotrigine (LTG) in patients with localization-related epilepsies.
- To assess the impact of LTG on electrocardiogram (ECG) parameters.
Main Methods:
- 20 patients with localization-related epilepsies were studied.
- LTG was added to existing antiepileptic drug (AED) regimens.
- Regular physical examinations and ECG recordings were performed.
Main Results:
- No clinical cardiac side effects were observed.
- Non-specific ECG abnormalities were seen in only six patients.
- No statistically significant changes in ventricular activation times were found, with minor exceptions attributed to patient group differences.
Conclusions:
- Lamotrigine (LTG) does not appear to increase the risk of clinically relevant cardiovascular side effects.
- The study provides evidence against significant cardiac risks associated with LTG treatment in epilepsy patients.